{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:24:05Z","timestamp":1794291845019,"version":"4.9.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100002597","name":"Kyung Hee University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002597","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministry of Education"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1007\/s00228-026-04193-6","type":"journal-article","created":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:13:36Z","timestamp":1791274416000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Machine learning\u2013driven pharmacovigilance of antidiabetic drugs: comparative reporting patterns and classification of serious adverse events"],"prefix":"10.1007","volume":"82","author":[{"given":"Soo Hyeon","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seojun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangyoon Chris","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0635-4374","authenticated-orcid":false,"given":"Yeo Jin","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,6]]},"reference":[{"issue":"10397","key":"4193_CR1","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/s0140-6736(23)01301-6","volume":"402","author":"KL Ong","year":"2021","unstructured":"Ong KL, Stafford LK, McLaughlin SA et al (2021) Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 402(10397):203\u2013234. https:\/\/doi.org\/10.1016\/s0140-6736(23)01301-6","journal-title":"Lancet"},{"issue":"1 Suppl 1","key":"4193_CR2","doi-asserted-by":"publisher","first-page":"S50","DOI":"10.2337\/dc25-S003","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) Prevention or delay of diabetes and associated comorbidities: Standards of care in diabetes-2025. Diabetes Care 48(1 Suppl 1):S50\u2013S8. https:\/\/doi.org\/10.2337\/dc25-S003","journal-title":"Diabetes Care"},{"issue":"1 Suppl 1","key":"4193_CR3","doi-asserted-by":"publisher","first-page":"S181","DOI":"10.2337\/dc25-S009","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) Pharmacologic approaches to glycemic treatment: Standards of care in Diabetes-2025. Diabetes Care 48(1 Suppl 1):S181\u2013S206. https:\/\/doi.org\/10.2337\/dc25-S009","journal-title":"Diabetes Care"},{"issue":"2","key":"4193_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/0897190015594732","volume":"30","author":"OF Akiyode","year":"2017","unstructured":"Akiyode OF, Adesoye AA (2017) Adverse effects associated with newer diabetes therapies. J Pharm Pract 30(2):238\u2013244. https:\/\/doi.org\/10.1177\/0897190015594732","journal-title":"J Pharm Pract"},{"issue":"2","key":"4193_CR5","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1177\/2042018816638050","volume":"7","author":"M May","year":"2016","unstructured":"May M, Schindler C (2016) Clinically and pharmacologically relevant interactions of antidiabetic drugs. Ther Adv Endocrinol Metab 7(2):69\u201383. https:\/\/doi.org\/10.1177\/2042018816638050","journal-title":"Ther Adv Endocrinol Metab"},{"issue":"1","key":"4193_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41392-023-01400-z","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Liu Y, Liu S et al (2023) Diabetic vascular diseases: molecular mechanisms and therapeutic strategies. Signal Transduct Target Ther 8(1):152. https:\/\/doi.org\/10.1038\/s41392-023-01400-z","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"4193_CR7","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1097\/med.0000000000000896","volume":"32","author":"LT Ong","year":"2025","unstructured":"Ong LT, Sia CH (2025) Interactions between antidiabetes medications and heart-brain axis. Curr Opin Endocrinol Diabetes Obes 32(1):34\u201343. https:\/\/doi.org\/10.1097\/med.0000000000000896","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"4","key":"4193_CR8","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","volume":"61","author":"E Von Elm","year":"2008","unstructured":"Von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP (2008) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol 61(4):344\u20139. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008","journal-title":"J Clin Epidemiol"},{"key":"4193_CR9","unstructured":"The Uppsala Monitoring Centre (2021) The use of the WHO\u2013UMC system for standardised case causality assessment. https:\/\/www.who.int\/docs\/default-source\/medicines\/pharmacovigilance\/whocausality-assessment.pdf. Accessed 25 August 2025"},{"key":"4193_CR10","unstructured":"Korea Institute of Drug Safety & Risk Management (KIDS) (2025) Guide for the Use of the Korea Adverse Event Reporting System (KAERS) Database: Research, Medical, and Public Institution Version. Version 15. Anyang, Republic of Korea: Korea Institute of Drug Safety & Risk Management (Korean). https:\/\/nedrug.mfds.go.kr\/bbs\/148\/40\/. Accessed 30 May 2025"},{"key":"4193_CR11","unstructured":"International Conference on Harmonisation (2003) Post\u2013Aproval Safety Data Management: Definitions and Standard for Expedites Reporting E2D. https:\/\/database.ich.org\/sites\/default\/files\/E2D_Guideline.pdf. Accessed August 25, 2025"},{"issue":"7","key":"4193_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ph18071013","volume":"18","author":"SH Lee","year":"2025","unstructured":"Lee SH, Sung DH, Cho E et al (2025) Investigation into safety profiles of antiepileptic drugs and identification of predictors for serious adverse events: insights from national pharmacovigilance data. Pharmaceuticals (Basel) 18(7):1013. https:\/\/doi.org\/10.3390\/ph18071013","journal-title":"Pharmaceuticals (Basel)"},{"key":"4193_CR13","doi-asserted-by":"publisher","DOI":"10.7189\/jogh.13.04095","volume":"13","author":"YJ Choi","year":"2023","unstructured":"Choi YJ, Choi CY, Kim CU, Shin S (2023) A nationwide pharmacovigilance investigation on trends and seriousness of adverse events induced by anti-obesity medication. J Glob Health 13:04095. https:\/\/doi.org\/10.7189\/jogh.13.04095","journal-title":"J Glob Health"},{"issue":"6","key":"4193_CR14","doi-asserted-by":"publisher","first-page":"743","DOI":"10.4093\/dmj.2023.0018","volume":"47","author":"HH Jang","year":"2023","unstructured":"Jang HH, Oh TJ (2023) Pharmacological and nonpharmacological treatments for painful diabetic peripheral neuropathy. Diabetes Metab J 47(6):743\u2013756. https:\/\/doi.org\/10.4093\/dmj.2023.0018","journal-title":"Diabetes Metab J"},{"issue":"8","key":"4193_CR15","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1007\/s13300-024-01612-8","volume":"15","author":"I Sahin","year":"2024","unstructured":"Sahin I, Bakiner O, Demir T, Sari R, Atmaca A (2024) Current position of gliclazide and sulfonylureas in the contemporary treatment paradigm for type 2 diabetes: a scoping review. Diabetes Ther 15(8):1687\u2013716. https:\/\/doi.org\/10.1007\/s13300-024-01612-8","journal-title":"Diabetes Ther"},{"issue":"18","key":"4193_CR16","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.122.026289","volume":"11","author":"TTL Lee","year":"2022","unstructured":"Lee TTL, Hui JMH, Lee YHA et al (2022) Sulfonylurea is associated with higher risks of ventricular arrhythmia or sudden cardiac death compared with metformin: a population-based cohort study. J Am Heart Assoc 11(18):e026289. https:\/\/doi.org\/10.1161\/jaha.122.026289","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"4193_CR17","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/nyas.13872","volume":"1431","author":"L Smith","year":"2018","unstructured":"Smith L, Chakraborty D, Bhattacharya P et al (2018) Exposure to hypoglycemia and risk of stroke. Ann N Y Acad Sci 1431(1):25\u201334. https:\/\/doi.org\/10.1111\/nyas.13872","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"4193_CR18","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.amepre.2024.04.014","volume":"67","author":"Y Sunwoo","year":"2024","unstructured":"Sunwoo Y, Park J, Choi CY et al (2024) Risk of dementia and Alzheimer\u2019s disease associated with antidiabetics: A Bayesian network meta-analysis. Am J Prev Med 67(3):434\u2013443. https:\/\/doi.org\/10.1016\/j.amepre.2024.04.014","journal-title":"Am J Prev Med"},{"issue":"1 Suppl 1","key":"4193_CR19","doi-asserted-by":"publisher","first-page":"S266","DOI":"10.2337\/dc25-S013","volume":"48","author":"American Diabetes Association Professional Practice Committee","year":"2025","unstructured":"American Diabetes Association Professional Practice Committee (2025) Older adults: Standards of care in diabetes-2025. Diabetes Care 48(1 Suppl 1):S266\u2013S82. https:\/\/doi.org\/10.2337\/dc25-S013","journal-title":"Diabetes Care"},{"issue":"8","key":"4193_CR20","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.302","volume":"7","author":"MU Nisar","year":"2015","unstructured":"Nisar MU, Asad A, Waqas A et al (2015) Association of diabetic neuropathy with duration of type 2 diabetes and glycemic control. Cureus 7(8):e302. https:\/\/doi.org\/10.7759\/cureus.302","journal-title":"Cureus"},{"issue":"5","key":"4193_CR21","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1007\/s00702-025-02882-7","volume":"132","author":"O Stockmann","year":"2025","unstructured":"Stockmann O, Ye L, Greten S et al (2025) Impact of diabetes mellitus type two on incidence and progression of Parkinson\u2019s disease: a systematic review of longitudinal patient cohorts. J Neural Transm (Vienna) 132(5):627\u2013635. https:\/\/doi.org\/10.1007\/s00702-025-02882-7","journal-title":"J Neural Transm (Vienna)"},{"key":"4193_CR22","doi-asserted-by":"publisher","unstructured":"Szablewski L (2025) Associations between diabetes mellitus and neurodegenerative diseases. Int J Mol Sci 26(2). https:\/\/doi.org\/10.3390\/ijms26020542","DOI":"10.3390\/ijms26020542"},{"issue":"10","key":"4193_CR23","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41574-018-0048-7","volume":"14","author":"GJ Biessels","year":"2018","unstructured":"Biessels GJ, Despa F (2018) Cognitive decline and dementia in diabetes mellitus: mechanisms and clinical implications. Nat Rev Endocrinol 14(10):591\u2013604. https:\/\/doi.org\/10.1038\/s41574-018-0048-7","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"4193_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-31797-2","volume":"16","author":"M Poorrezaei","year":"2025","unstructured":"Poorrezaei M, Zakeri MA, Kamiab Z et al (2025) Associations between peripheral neuropathy and cardiovascular complications in patients with type 2 diabetes mellitus: a cross-sectional study. Sci Rep 16(1):2129. https:\/\/doi.org\/10.1038\/s41598-025-31797-2","journal-title":"Sci Rep"},{"issue":"2","key":"4193_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/fjc.0000000000000599","volume":"72","author":"C Driver","year":"2018","unstructured":"Driver C, Bamitale KDS, Kazi A et al (2018) Cardioprotective effects of metformin. J Cardiovasc Pharmacol 72(2):121\u2013127. https:\/\/doi.org\/10.1097\/fjc.0000000000000599","journal-title":"J Cardiovasc Pharmacol"},{"issue":"5","key":"4193_CR26","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.4103\/1673-5374.385286","volume":"19","author":"A Loan","year":"2024","unstructured":"Loan A, Syal C, Lui M et al (2024) Promising use of metformin in treating neurological disorders: biomarker-guided therapies. Neural Regen Res 19(5):1045\u20131055. https:\/\/doi.org\/10.4103\/1673-5374.385286","journal-title":"Neural Regen Res"},{"issue":"19","key":"4193_CR27","doi-asserted-by":"publisher","first-page":"9376","DOI":"10.7150\/thno.64706","volume":"11","author":"Y Ding","year":"2021","unstructured":"Ding Y, Zhou Y, Ling P et al (2021) Metformin in cardiovascular diabetology: a focused review of its impact on endothelial function. Theranostics 11(19):9376\u20139396. https:\/\/doi.org\/10.7150\/thno.64706","journal-title":"Theranostics"},{"issue":"5","key":"4193_CR28","doi-asserted-by":"publisher","first-page":"e0126413","DOI":"10.1371\/journal.pone.0126413","volume":"10","author":"S Matsuda","year":"2015","unstructured":"Matsuda S, Aoki K, Kawamata T et al (2015) Bias in spontaneous reporting of adverse drug reactions in Japan. PLoS ONE 10(5):e0126413. https:\/\/doi.org\/10.1371\/journal.pone.0126413","journal-title":"PLoS ONE"},{"issue":"5","key":"4193_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SAW (2006) Under-reporting of adverse drug reactions: a systemtatic review. Drug Saf 29(5):385\u2013396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003","journal-title":"Drug Saf"},{"issue":"21","key":"4193_CR30","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","volume":"365","author":"DS Budnitz","year":"2011","unstructured":"Budnitz DS, Lovegrove MC, Shehab N et al (2011) Emergency hospitalizations for adverse drug events in older Americans. N Engl J Med 365(21):2002\u20132012. https:\/\/doi.org\/10.1056\/NEJMsa1103053","journal-title":"N Engl J Med"},{"key":"4193_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fdsfr.2023.1323057","volume":"3","author":"PM Cutroneo","year":"2024","unstructured":"Cutroneo PM, Sartori D, Tuccori M et al (2024) Conducting and interpreting disproportionality analyses derived from spontaneous reporting systems. Front Drug Saf Regul 3:1323057. https:\/\/doi.org\/10.3389\/fdsfr.2023.1323057","journal-title":"Front Drug Saf Regul"},{"key":"4193_CR32","doi-asserted-by":"publisher","unstructured":"Pilipiec P, Liwicki M, Bota A (2022) Using machine learning for pharmacovigilance: A systematic review. Pharmaceutics 14(2). https:\/\/doi.org\/10.3390\/pharmaceutics14020266","DOI":"10.3390\/pharmaceutics14020266"},{"issue":"3","key":"4193_CR33","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s40290-025-00561-2","volume":"39","author":"J Warner","year":"2025","unstructured":"Warner J, Prada Jardim A, Albera C (2025) Artificial intelligence: Applications in pharmacovigilance signal management. Pharmaceut Med 39(3):183\u2013198. https:\/\/doi.org\/10.1007\/s40290-025-00561-2","journal-title":"Pharmaceut Med"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04193-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04193-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-026-04193-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:17:54Z","timestamp":1794291474000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00228-026-04193-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,6]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["4193"],"URL":"https:\/\/doi.org\/10.1007\/s00228-026-04193-6","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,6]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The protocol of utilizing KAERS DB was approved by Korea Institute of Drug Safety & Risk Management (Ministry of Food and Drug Safety) (KAERS DB 2505A0010), and the study protocol was approved by the Kyung Hee University Institutional Review Board (IRB) (KHSIRB-25-451).","order":1,"name":"Ethics","label":"Institutional review board statement\/ethics declarations","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"266"}}